Search

everythinglearnresearchcommunity

for

Search:↓

Inconsistent platelet counts in PRP are due to varying blood volumes, preparation methods, and analyzer types.

Domestic and imported finasteride tablets are bioequivalent.

Botulinum toxin, once seen as a poison, is now used to treat medical conditions and is unlikely to be an effective biological weapon.

Drug repositioning can save time and money but needs more support.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The new biodegradable nanocarriers safely and effectively deliver drugs into the skin.

New technologies replicate human skin for testing without animals.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

The two finasteride tablets are bioequivalent.

Plant bioactive compounds are important for health and can help prevent various diseases.

The document concludes that more research is needed on making and understanding biomaterial scaffolds for wound healing.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Polyglutamic acid is a valuable, sustainable ingredient for skincare and haircare products.

Two finasteride preparations are bioequivalent.

Biomedical innovations could extend human lifespan, but may impact pension systems.

The microneedle system shows promise for non-invasive brain drug delivery.

Platelet-derived exosomes offer better regenerative therapy but face challenges in isolation and regulation.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Future work on macrolide antibiotic analysis will aim to enhance selectivity, sensitivity, and efficiency using advanced chromatographic methods.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

The same drug is priced differently based on its use.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

The new topical growth hormone formula has high skin penetration and bioavailability.